This one-day event brings together a diverse group of experts to discuss crucial topics at the intersection of haematology and critical care.
This one-day event brings together a diverse group of experts to discuss crucial topics at the intersection of haematology and critical care. Our distinguished faculty will cover a wide range of subjects, including the management of sickle cell anaemia, red cell and platelet transfusions in an ICU setting, and the challenges of treating cytokine release syndrome and ICANs in critically ill patients.
We will also explore the potential for VV-ECMO in patients with malignancy and delve into the latest research on immunothrombosis and models of haemostasis and thrombosis. Attendees will gain valuable insights into monitoring anticoagulation in critical care, diagnosing and managing heparin-induced thrombocytopenia, and the treatment of TTP in the critical care setting. This comprehensive program is designed to enhance the knowledge and skills of consultants, junior doctors, and allied health care professionals working in intensive care.
Group bookings can be made for multiple delegates and paid by credit card via the event booking page.
We are also able to invoice for group bookings of 10 or more delegates, or where the total value is over £1,000. Group bookings can only be made up to 6 weeks in advance of an event and must be paid in full prior to the event date to avoid tickets being cancelled.
To book a group via invoice, please download the form below, complete and return to events@ics.ac.uk.
If you have any questions about the event or need any further assitance, please do contact us via:
Telephone: (+44) 0207 280 4350
Email:
Full Professor Intensive Care Medicine, Amsterdam UMC
Principal Pharmacist for Adult Critical Care, Guy's and St Thomas' NHS Foundation Trust
Consultant Haematologist, Leeds Teaching Hospitals NHS Trust
Consultant Haematologist, John Radcliffe Hospital (Oxford University Hospitals Foundation Trust)
ECMO Fellow, Guy's and St Thomas' NHS Foundation Trust
Clinical Lead for Intensive Care at Guys and St. Thomas’, UK
Andrew Retter is Clinical Lead for Intensive Care at Guys and St. Thomas’
He qualified from St. George’s (London) in 2001 and has worked as a consultant since 2014.
Dr Retter has academic interests in transfusion, Haemostasis and immunothrombosis and in particular the relationship to sepsis.
Consultant Haematologist
Andrew is a consultant haematologist at Guy’s & St Thomas’ NHS Foundation Trust in London where he specialises in treating a variety of thrombotic and bleeding disorders and vascular malformations. He is clinical lead for the regional Haemostasis and Thrombosis laboratory providing diagnostic support to London and South East England. His research interests include understanding acquired coagulopathies in critical illness and extracorporeal devices and developing safe and effective anticoagulation strategies, with previous doctoral studies in these areas with King’s College London.
Consultant Haematologist
Claire is a Consultant Haematologist at UCLH and Associate Professor in Haematology at UCL with a particular interest in adoptive cell therapies. She completed an Immunotherapy PhD at UCL with Karl Peggs and subsequently undertook a clinician scientist role with Martin Pule to develop the UCL CAR-T program.
Claire’s current role involves pre-clinical development of novel cell therapy projects, GMP manufacture and clinical trial design. She is also responsible for the advanced therapies clinical service at UCLH.
Consultat Haematologist , UK
Dr Rachel Kesse-Adu is a consultant haematologist who graduated in medicine from Imperial College School of Medicine in 2002, she completed her specialist training in haematology at Kings College Hospital in London in 2012 and was appointed to a Consultant Haematologist position at Guy’s and St Thomas Hospital where she continues to work and was appointed to the clinical lead position for the department in March 2022.
Dr Kesse-Adu has specialist interest in Sickle cell disease, her particular areas of interest in sickle are cardiorespiratory, chronic pain and urological complications of the condition, she runs joint specialist clinics in these areas. She is actively involved in clinical research in sickle cell disease and is chief and principal investigator on a number of ongoing trials. She is additionally medical advisor to the UK Sickle Cell Society and Treasurer for the UK forum on haemoglobin disorders.
Dr Kesse-Adu also has an interest in post graduate medical education and is heavily involved in teaching and training of haematology specialist trainees.
Consultant Haematologist, University College London Hospitals
Professor Marie Scully MBE: Consultant haematologist at UCLH and Professor of haemostasis and thrombosis at UCL. My particular interests include platelet mediated disorders, specifically, ITP, TTP and aHUS and acquired bleeding and thrombotic conditions. Primary publications include TTP, in particular treatment and clinical subtypes, in conjunction with an understanding of the pathogenesis of the underlying disease. I am clinical lead for the national TTP service, UK TTP forum and patron for the TTP Network. I supervise postgraduate doctorates and am involved in undergraduate and postgraduate teaching and regularly reviews for haematology and related medical journals.
Consultant Haematologist, John Radcliffe Hospital (Oxford University Hospitals Foundation Trust)
Simon Stanworth is Consultant Haematologist at the John Radcliffe Hospital in Oxford (NHSBT and Oxford University Hospitals Foundation Trust), and Professor of Haematology and Transfusion Medicine, University of Oxford. His research is driven by patient needs, identified by Patient and Public Engagement panels and James Lind Priority Setting Partnerships. The primary aim of the research is to understand which patients need (or don’t need) blood or alternatives to blood transfusion. Highlights have included international randomized trials published in high impact publications. He has an interest in translating research into practice, through research on audit & feedback and through leadership for national/international guidelines. He is Director of the NIHR Blood Transfusion Research Unit (BTRU) Data Enabled Transfusion Practice.